Skip to content 
1 / 6
Laboratory Research Material
Cartalax 20mg
Research Studies:
- Facilitates analysis of tissue-specific gene expression within the musculoskeletal system and cartilage tissue
- Supports investigation into the regulation of collagen type II and proteoglycan synthesis pathways
- Enables research on the modulation of inflammatory cytokine expression and oxidative stress in chondrocytes
- Useful for evaluating the epigenetic regulation of cellular repair mechanisms in connective tissue assay models
Important
Research Use Notice
All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
Product Documentation
Details, specifications, and reviews
Description
Cartalax 20mg is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.
Key Product Details
- Manufactured in accordance with rigorous quality standards to support ≥99% purity, as reflected in batch-specific documentation where available.
- Every batch is third-party analyzed for identity, assay/potency, and sterility documentation where applicable.
- Supplied in lyophilized powder form to help preserve stability throughout transport and storage.
- Produced with lot-level traceability to support research documentation and laboratory recordkeeping.
Research Documentation Context
- Supports compound characterization in controlled laboratory settings.
- Provides batch-specific identity and purity documentation for research review.
- Allows lot-level traceability across laboratory documentation workflows.
- Supports comparison of product labeling, analytical documentation, and storage information during research planning.
- Supports analytical review of short peptide research materials within a strictly laboratory-focused context.
Specifications and Documentation
- Certificate of Analysis: Available with batch-specific documentation where applicable.
- Material Safety Data Sheet: Coming Soon.
- Handling and Storage Instructions: Coming Soon.
- Product Form: Lyophilized powder.
- Purity Specification: ≥99% purity.
- Intended Use: Laboratory research use only.
Cartalax 20mg is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.
Additional information
| CAS No. | Not officially assigned (peptide bioregulator complex) |
|---|---|
| Molecular Formula | Peptide complex (exact structure proprietary) |
| Molecular Weight | Varies (approx. low molecular weight peptide fraction) |
| Purity | ≥99% |
| Sequence | Not publicly disclosed (peptide complex derived from calf cartilage) |
| Synthesis Method | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Water/Sterile Diluent |
| Stability & Storage | Up to 24 months at -20°C. Avoid repeated freeze-thaw cycles. |
| Applications | Cartilage regeneration, joint health research, musculoskeletal tissue studies |
| Appearance | White to off-white powder |
| Regulatory/Compliance | Not for human consumption. For research use only. |
| Safety Information | MSDS available upon request |
Only logged in customers who have purchased this product may leave a review.
Need Assistance?
Questions about product documentation?
Our support team can assist with product records, lot information, order questions, and certificate verification.
There are no reviews yet.